//./ActionParams/@language -> $page_language ->

Never miss a great news story!
Get instant notifications from Economic Times
AllowNot now


You can switch off notifications anytime using browser settings.
8,083.80-170.0
Stock Analysis, IPO, Mutual Funds, Bonds & More

Abbott India Ltd.

ET 500

Rank 2019
339
ENGNew
  • ENG - English
  • HIN - हिन्दी
  • GUJ - ગુજરાતી
  • MAR - मराठी
  • BEN - বাংলা 
  • KAN - ಕನ್ನಡ 
  • ORI - ଓଡିଆ
  • TEL - తెలుగు
  • TAM - தமிழ்
  • NSE
    15:59 | 03-04-2020
  • BSE
    12:00 | 03-04-2020
15810.50

Today's Change

196.90 (1.26%)

Volume
AVERAGE VOLUME
5-Day
10-Day
30-Day

28,827

Open

15775.00

Prev. Close

15613.60

Day's Trend

  • Bid
  • Mkt Cap (₹ Cr.)
  • P/E (x)
  • P/B (x)
  • Div_ Yield (%)
  • BETA
    BETA
    1 Month
    3-Months
    6-Months
    1 Year
    3-Years
  • Offer
  • Face Value (₹)10.00
  • EPS-TTM (Rs.)280.08
  • BV/share (₹)945.25
  • 52Wk L/H6900.00/ 16495.00
  • Avg. Daily Volatility %
    Avg. Daily Volatility %
    1 Month
    3-Months
    6-Months
    1 Year
    3-Years
InsightsEvents| Recos| Updates| News
Abbott India Ltd.Clarifies on News item| Announcement
Abbott India Ltd.Closure of Trading Window| Announcement
Abbott India Ltd.Clarification sought from Abbott India Ltd| Announcement
Jawed Zia quits Abbott India| News
Abbott India Ltd.Announcement under Regulation 30 (LODR)-Change in Directorate| Announcement
Abbott India Ltd.Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate| Announcement
Abbott India Ltd.Announcement under Regulation 30 (LODR)-Newspaper Publication| Announcement
Abbott India Ltd.Unaudited Financial Results For The Third Quarter And Nine Months Ended On December 31, 2019| Announcement
Abbott India Ltd.Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate| Announcement
Abbott India Ltd.Changes In Fax No, Email And Website Of The Registrar And Share Transfer Agent Of The Company| Announcement
Abbott India Ltd.Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate| Announcement
Abbott India Ltd.Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate| Announcement
Abbott India Ltd.Announcement under Regulation 30 (LODR)-Newspaper Publication| Announcement
Abbott India Ltd.Board Meeting Intimation for Approving The Text Of The Unaudited Financial Results Of The Company For The Third Quarter ...| Announcement
Abbott India Ltd.Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate| Announcement
Abbott India Ltd.Shareholding for the Period Ended December 31, 2019| Announcement
Abbott India Ltd.Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018| Announcement
Abbott India Ltd.Statement Of Investor Complaints For The Quarter Ended December 2019| Announcement
Abbott India Ltd.Closure of Trading Window| Announcement
Abbott India Ltd.Change In Name Of Registrar And Share Transfer Agent Of The Company| Announcement
Abbott India Ltd.Changes In Telephone And Fax Nos. Of The Company| Announcement
Abbott India Q2 profit rises 30% to Rs 178 crore| News
Abbott India Q1 profit up 42% to Rs 117 crore| News

Abbott India Ltd. Share Price Updates

Abbott India Ltd. share price up by 1.26% from its previous close of Rs 15613.60. Abbott India Ltd. stock last traded price is 15810.50
Abbott India Ltd. Share Price
Value
Today/Current/Last
15810.50
Previous Day
15613.60
What's your view on Abbott India for the week?
Bearish
Bullish
View community Outlook >>

Be the first one to post on Abbott India Ltd.

Abbott India Ltd.
Quarterly Results

Figures in Rs. Cr
Dec 2019 
% Chg (Quarterly)
% Chg (Yearly)
Peer Range
Trend
Last 12 Quarters Trend
Sales
1,078.25
2.22
13.78
0.29
1078.25
Other Operating Income
0.00
0.00
0.00
0.00
0.00
Operating Profit
239.70
17.43
63.63
0.03
616.94
Other Income
27.76
-3.94
-26.23
0.00
58.22
EBITDA
267.46
14.77
45.26
0.03
616.94
Interest
1.86
2.20
332.56
0.00
2.98
Depreciation
15.05
0.67
280.05
0.00
24.70
Tax
63.86
68.36
1.88
-0.82
64.00
Net Profit
186.69
4.69
59.50
-644.14
186.69
EPS (₹)
87.85
4.67
59.50
-38.02
87.85

Abbott India Ltd Share Price

Vs Peers
Companies
LTP
Intraday
1W %
1M %
1 QTR %
1 YR %
3 YR %
5 Yr %
Trend -
D|M|Y
15810.50
1.26
9.85
2.48
19.34
115.73
231.66
297.12
1224.20
1.15
2.09
-6.75
-24.01
-5.66
-10.49
-26.98
4020.00
1.35
3.01
-9.11
-4.26
22.74
107.67
81.37
6655.65
3.03
8.85
-9.94
-3.54
12.71
39.05
98.58
2401.05
-0.34
6.57
-9.72
-6.52
20.18
152.03
160.88
3847.10
5.02
11.63
-3.89
-12.18
2.90
262.20
321.23
Top Loser for the period amongst the peers
Top Gainer for the period amongst the peers

Abbott India Ltd Risk Return Comparison

with peersNew
Better performer than its peers on this ratioAverage performer than its peers on this ratioUnderperformer than its peers on this ratio

Abbott India Ltd Share Holding as on 31-12-2019

CategoryNo. of sharesPercentage
ForeignInstitutions386,1431.82
Others518,3892.44
NBanksMutualFunds1,057,9834.98
GeneralPublic3,080,17614.50
FinancialInstitutions272,5631.28
ForeignPromoter15,934,04874.99

MF Ownership Of Abbott India Ltd. Shares

Fund Name
Category
No. of shares
% Change in Shares (MOM basis)
% of AUM
Amount Invested (in ₹ Cr)
Nippon India Pharma Direct-G
Portfolio as on 29-02-2020
Equity: Sectoral-Pharma
122809
-11.21%
7.97%
193.04
L&T Midcap Direct-G
Portfolio as on 29-02-2020
Equity: Mid Cap
92690
0.00%
2.35%
145.70
L&T Emerging Businesses Direct-G
Portfolio as on 29-02-2020
Equity: Small Cap
86567
-5.46%
2.43%
136.07
Equity: Large & MidCap
63000
18.87%
1.77%
99.03
L&T Tax Adv Direct-G
Portfolio as on 29-02-2020
Equity: ELSS
50000
0.00%
2.45%
78.59

Liquid, Ultra Short Term funds and FMPs are not taken into account.

More Schemes

About Abbott India Ltd.

Abbott India Ltd., incorporated in the year 1944, is a Large Cap company (having a market cap of Rs 33630.42 Crore) operating in Pharmaceuticals sector.

Abbott India Ltd. key Products/Revenue Segments include Injectables which contributed Rs 1507.14 Crore to Sales Value (40.97 % of Total Sales), Tablets which contributed Rs 1421.77 Crore to Sales Value (38.64 % of Total Sales), Liquids which contributed Rs 512.56 Crore to Sales Value (13.93 % of Total Sales), Capsules which contributed Rs 130.25 Crore to Sales Value (3.54 % of Total Sales), Others which contributed Rs 35.50 Crore to Sales Value (0.96 % of Total Sales), Service Income which contributed Rs 22.02 Crore to Sales Value (0.59 % of Total Sales), Ointments which contributed Rs 15.92 Crore to Sales Value (0.43 % of Total Sales), Other Operating Revenue which contributed Rs 15.37 Crore to Sales Value (0.41 % of Total Sales), Granules which contributed Rs 9.57 Crore to Sales Value (0.26 % of Total Sales), Powder which contributed Rs 7.58 Crore to Sales Value (0.20 % of Total Sales), Scrap which contributed Rs .69 Crore to Sales Value (0.01 % of Total Sales), Duty Drawback which contributed Rs .23 Crore to Sales Value (0.00 % of Total Sales)for the year ending 31-Mar-2019.

For the quarter ended 31-12-2019, the company has reported a Standalone sales of Rs 1078.25 Crore, up 2.22 % from last quarter Sales of Rs 1054.80 Crore and up 13.78 % from last year same quarter Sales of Rs 947.65 Crore Company has reported net profit after tax of Rs 186.69 Crore in latest quarter.

The company’s top management includes Mr.Ambati Venu, Mr.Kaiyomarz Marfatia, Mr.Mark Murphy II, Mr.Munir Shaikh, Mr.Rajiv Sonalker, Mr.Sudarshan Jain, Ms.Anisha Motwani, Ms.Shalini Kamath. Company has SRBC & Co LLP as its auditors As on 31-12-2019, the company has a total of 21,249,302 shares outstanding.

Close X
WatchlistPortfolio

Current Price>: 2389.88

Set Alert

Loading
Please wait...

Date Sources:Live BSE and NSE Quotes Service: TickerPlant | Corporate Data, F&O Data & Historical price volume data: Dion Global Solutions Ltd.
BSE Quotes and Sensex are real-time and licensed from the Bombay Stock Exchange. NSE Quotes and Nifty are also real time and licenced from National Stock Exchange. All times stamps are reflecting IST (Indian Standard Time).
By using this site, you agree to the Terms of Service and Privacy Policy.

Other useful Links


Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service

Loadingdata
More on:
Prices| Financials | Company Info | Reports | News | Competitors